產(chǎn)品中(zhōng)心(xīn)
一抗
英文名稱 Anti-BCSC1
中文名稱： 乳腺(xiàn)癌(ái)抑癌蛋白(bái)抗(kàng)體(tǐ)
別 名 Breast cancer suppressor candidate 1; LOH11CR2A; LHR2A; LOH11CR2A; BCSC 1; BCSC-1; BCSC1; Breast cancer suppressor candidate-1; Loss of heterozygosity 11 chromosomal region 2 gene A; Loss of heterozygosity 11 chromosomal region 2 gene A protein; Ortholog of mouse AW551984; VMA5A_HUMAN; von Willebrand factor A domain containing 5A; von Willebrand factor A domain-containing protein 5A; Vwa5a.
濃 度 1mg/1ml
規 格 0.2ml/200μg
抗體來源 Rabbit
克(kè)隆類(lèi)型 polyclonal
交(jiāo)叉反應(yīng) Human, Mouse, Rat
產品(pǐn)類(lèi)型 一(yī)抗
研究領(lǐng)域(yù) 腫(zhǒng)瘤 細胞生(shēng)物 免(miǎn)疫學(xué)
蛋白分子(zǐ)量(liáng) predicted molecular weight: 86kDa
性 狀(zhuàng) Lyophilized or Liquid
免(miǎn) 疫(yì) 原 KLH conjugated synthetic peptide derived from human BCSC1
亞 型 IgG
純(chún)化方(fāng)法(fǎ) affinity purified by Protein A
儲 存(cún) 液(yè) 0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodium azide
產品應用 WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
（石蠟切(qiē)片(piàn)需(xū)做抗原修復）
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
保存條(tiáo)件(jiàn) Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
Important Note This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
產品(pǐn)介紹 May play a role in tumorigenesis as a tumor suppressor. Altered expression of this protein and disruption of the molecular pathway it is involved in, may contribute directly to or modify tumorigenesis.
Function : May play a role in tumorigenesis as a tumor suppressor. Altered expression of this protein and disruption of the molecular pathway it is involved in, may contribute directly to or modify tumorigenesis.
Tissue Specificity : Expressed at low level in many tissues. Not expressed in 80% of tumor cell lines tested.
Similarity : Contains 1 VIT domain.
Contains 1 VWFA domain.
Database links : UniProtKB/Swiss-Prot: O00534.2
中文名稱： 乳腺(xiàn)癌(ái)抑癌蛋白(bái)抗(kàng)體(tǐ)
別 名 Breast cancer suppressor candidate 1; LOH11CR2A; LHR2A; LOH11CR2A; BCSC 1; BCSC-1; BCSC1; Breast cancer suppressor candidate-1; Loss of heterozygosity 11 chromosomal region 2 gene A; Loss of heterozygosity 11 chromosomal region 2 gene A protein; Ortholog of mouse AW551984; VMA5A_HUMAN; von Willebrand factor A domain containing 5A; von Willebrand factor A domain-containing protein 5A; Vwa5a.
詳(xiáng)細(xì)介紹(shào)：
濃 度 1mg/1ml
規 格 0.2ml/200μg
抗體來源 Rabbit
克(kè)隆類(lèi)型 polyclonal
交(jiāo)叉反應(yīng) Human, Mouse, Rat
產品(pǐn)類(lèi)型 一(yī)抗
研究領(lǐng)域(yù) 腫(zhǒng)瘤 細胞生(shēng)物 免(miǎn)疫學(xué)
蛋白分子(zǐ)量(liáng) predicted molecular weight: 86kDa
性 狀(zhuàng) Lyophilized or Liquid
免(miǎn) 疫(yì) 原 KLH conjugated synthetic peptide derived from human BCSC1
亞 型 IgG
純(chún)化方(fāng)法(fǎ) affinity purified by Protein A
儲 存(cún) 液(yè) 0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodium azide
產品應用 WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
（石蠟切(qiē)片(piàn)需(xū)做抗原修復）
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
保存條(tiáo)件(jiàn) Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
Important Note This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
相(xiāng)關(guān)資(zī)料(liào)：
產品(pǐn)介紹 May play a role in tumorigenesis as a tumor suppressor. Altered expression of this protein and disruption of the molecular pathway it is involved in, may contribute directly to or modify tumorigenesis.
Function : May play a role in tumorigenesis as a tumor suppressor. Altered expression of this protein and disruption of the molecular pathway it is involved in, may contribute directly to or modify tumorigenesis.
Tissue Specificity : Expressed at low level in many tissues. Not expressed in 80% of tumor cell lines tested.
Similarity : Contains 1 VIT domain.
Contains 1 VWFA domain.
Database links : UniProtKB/Swiss-Prot: O00534.2
